British Columbia Investment Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

British Columbia Investment Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,900	Closed	-$258K	–	835
2022 Q1	$258K	Hold	15,900	–	–	﹤0.01%	835
2021 Q4	$754K	Buy	15,900 +2,400	+18%	+$144K	﹤0.01%	805
2021 Q3	$979K	Hold	13,500	–	–	0.01%	800
2021 Q2	$1.13M	Buy	+13,500	New	+$891K	0.01%	803

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

British Columbia Investment Management's NBP Position: Q2 2022 in Review

British Columbia Investment Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 15,900 shares — an estimated $258K sold.

British Columbia Investment Management first reported a position in NBP in Q2 2021 and held it in 4 quarters. The position peaked at $1.13M in Q2 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

British Columbia Investment Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
British Columbia Investment Management sold 15,900 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $258K.
British Columbia Investment Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 4 quarters.
British Columbia Investment Management's NovaBridge Biosciences American Depositary Shares position peaked at $1.13M in Q2 2021.
97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on British Columbia Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.